Device Trial Radar · NCT05597267
The MIRIA Acne Scar Study
Last checked: Nov 20, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Nov 4, 2022
Primary completion
Feb 28, 2025
Study completion Feb 28, 2025
Sponsor
- Lead sponsor
- AVAVA, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 28, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.
Conditions
- Acne Scars - Mixed Atrophic and Hypertrophic
Interventions
MIRIA LaserDevice
4-6 experimental treatments at 4-6 weeks intervals
Primary outcomes
What the sponsor says the trial is designed to measure.
- ECCA (échelle d'évaluation clinique des cicatrices d'acné) GradingTime frame: 3 months after the final treatment, Optional 6 months after final treatment
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Enchantress Dermatology
Miami, Florida
AVAVA, Inc.
Waltham, Massachusetts
Laser and Skin Surgery Center of New York
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.